You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 5, March 10, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Statistics and Research Methods
 •Cardiovascular Disease/ Myocardial Infarction
 •Adherence
 •Alert me on articles by topic

COMMENTS AND OPINIONS
Is Aspirin Resistance Due to Noncompliance?

James E. Dalen, MD, MPH

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The systematic review and meta-analysis of aspirin resistance by Snoep et al1 found that patients with laboratory resistance to aspirin also have clinical resistance to aspirin as evidenced by higher risks of recurrent cardiovascular events. A very likely explanation of this association is that laboratory resistance and clinical resistance have the same cause—noncompliance.2

Schwartz et al3 reported that 17 of 190 patients taking aspirin daily were determined to be aspirin resistant by light transmission aggregometry. When questioned, 10 of the 17 admitted that they were not taking the aspirin. When retested after they were observed to take 325 mg of aspirin, none of the 17 were aspirin resistant. Tantry et al4 reported that 7 of 203 patients with coronary heart disease had laboratory aspirin resistance. When retested after being observed ingesting aspirin, none were resistant.

Failure to take aspirin will cause laboratory resistance to aspirin . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED ARTICLE

Association of Laboratory-Defined Aspirin Resistance With a Higher Risk of Recurrent Cardiovascular Events: A Systematic Review and Meta-analysis
Jaapjan D. Snoep, Marcel M. C. Hovens, Jeroen C. J. Eikenboom, Johanna G. van der Bom, and Menno V. Huisman
Arch Intern Med. 2007;167(15):1593-1599.
ABSTRACT | FULL TEXT  

RELATED LETTER

Is Aspirin Resistance Due to Noncompliance?—Reply
Jaapjan D. Snoep, Marcel M. C. Hovens, Jeroen C. J. Eikenboom, Johanna G. van der Bom, and Menno V. Huisman
Arch Intern Med. 2008;168(5):550.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.